Human Angiogenesis Antibody Array
Breast cancer tissue array and normal tissue array |
|||
| BR726 | TissueArray | each | EUR 306 |
|
Description: Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases/72 cores |
|||
Human Antibody Laboratories manufactures the human angiogenesis antibody array reagents distributed by Genprice. The Human Angiogenesis Antibody Array reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human Antibody. Other Human products are available in stock. Specificity: Human Category: Angiogenesis Group: Antibody Array
Leiomyosarcoma and rhabdomyosarcoma tissue array |
||
| TissueArray | each | EUR 270 |
|
Description: Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM, 39 cases/72 cores, replacing SO751a |
||
JBS True Blue |
||
| Jena Bioscience GmbH | 300µl | EUR 13.7 |
JBS True Blue |
||
| MiTeGen | 300 µl | EUR 16 |
|
Description: JBS True Blue |
||
True Blue Chloride |
||
| Toronto Research Chemicals | 100mg | EUR 11200 |
|
Description: 71431-30-6 |
||
Lung small cell cancer array and normal lung tissue array |
||
| TissueArray | each | EUR 306 |
|
Description: Lung small cell cancer array and normal lung tissue array, including TNM and clinical stage, 50 cases/100 cores (1.0), replacing LC10010c |
||
Liver cancer and liver tissue array |
||
| TissueArray | each | EUR 306 |
|
Description: Liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 70 cases/70 cores, replacing BC03116 |
||
Liver cancer and normal tissue array |
||
| TissueArray | each | EUR 306 |
|
Description: Liver cancer and normal tissue array, including pathology grade, TNM and clinical stage, 70 cases/70 cores, replacing BC03116a |
||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC941326-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC941327-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC941327-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC401326-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF640R conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC401326-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF640R conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC401327-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF640R conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC401327-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF640R conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC471326-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF647 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC471326-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF647 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC471327-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF647 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC471327-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF647 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC051326-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF405M conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC051326-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF405M conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC051327-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF405M conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1327) Antibody |
|||
| BNC051327-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1327),CF405M conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC431326-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF543 conjugate, Concentration: 0.1mg/mL |
|||
Endoglin / CD105 (Angiogenesis Marker) (ENG/1326) Antibody |
|||
| BNC431326-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Endoglin / CD105 (Angiogenesis Marker) (ENG/1326),CF543 conjugate, Concentration: 0.1mg/mL |
|||